Optinose Announces Pricing of Initial Public Offering

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Oct 12, 2017 at 10:00 PM 153

YARDLEY, Pa., Oct. 12, 2017 (GLOBE NEWSWIRE) -- OptiNose, Inc. (Optinose), a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the pricing of its initial public offering of 7,500,000 shares of common stock at a public offering price of $16.00 per share, before underwriting discounts, for total gross proceeds of $120,000,000. All of the shares are being offered by Optinose. In addition, Optinose has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock at the initial public offering price, less the underwriting discount. The shares are scheduled to begin trading on the NASDAQ Global Select Market under the ticker symbol "OPTN" on Friday, October 13, 2017. The offering is expected to close on October 17, 2017, subject to the satisfaction of customary closing conditions. Jefferies and Piper Jaffray are acting as the lead joint book-running managers of the offering. BMO Capital Markets and RBC Capital Markets are also acting as joint book-running managers for the offering. A registration statement relating to the securities being sold in the offering was declared effective by the Securities and Exchange Commission on October 12, 2017. This offering is being made only by means of a prospectus. Copies of the final prospectus relating to this offering will be filed with the SEC and may be obtained, when available, from Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2^nd Floor, New York, NY 10022, or by telephone at 877-821-7388 or by email at Prospectus_Department@Jefferies.com; Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, or by telephone at 800-747-3924 or by email at prospectus@pjc.com; BMO Capital Markets Corp., Attention: Equity Syndicate Department, 3 Times Square, 25th Floor, New York, NY 10036, or by telephone at 800-414-3627 or by email at bmoprospectus@bmo.com; and RBC Capital Markets LLC, Attention: Equity Syndicate, 200 Vesey Street, 8^th Floor, New York, NY 10281-8098 or by telephone at 877-822-4089 or by email at equityprospectus@rbccm.com. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Optinose Optinose is a specialty pharmaceutical company on a mission to improve lives with a focus on patients cared for ear, nose and throat (ENT) or allergy specialists. The Company’s first two products rely on patented Exhalation Delivery Systems (EDS), which is capable of deep intranasal deposition of medication. These exhalation delivery systems enable the creation of products with the potential for meaningful new clinical benefits. Optinose developed its first product, Onzetra^® Xsail^® (sumatriptan nasal powder), through the completion of phase 3 and subsequently out-licensed the product to Ostuka Pharmaceutical Co., Ltd. Onzetra Xsail received FDA approval and was launched in the U.S. in 2016. The Company’s second product, XHANCE (fluticasone propionate) nasal spray, is approved for the treatment of nasal polyps in patients 18 years of age and older and is in development for the treatment of chronic sinusitis. We expect subsequent Optinose pipeline products will aim to serve the needs of patients treated by ENT and allergy specialists and are expected to include those using EDS and other technologies. The Company is also currently engaged in the early development of products for neurologic orphan diseases where the “nose-to-brain” application of an EDS may enable improved treatment. This includes OPN-300 (Prader-Willi Syndrome, Autism, others) and OPN-21 (narcolepsy and others). Optinose has corporate offices in the U.S., U.K. and Norway. Optinose Media Contact Kate Traynor, Sloane & Company Ktraynor@sloanepr.com 212.446.1871

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investigation of Maplebear Sale to DoorDash Sparks Debate

Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...

ScienceOra Unveils AI Catalyst Design at Tencent Summit

AI in Material Science: Beyond Buzzwords There's a lot of talk out there about AI changing the world, but it's always a different tune when it's put under a microscope. At the 2026 Tencent Global Digital Ecosystem Summit, ScienceOra and Wenge AI showcased an AI-assisted workflow for designing hydrogen-production catalysts. This isn't your average AI cheerleading session,...

Alignment Healthcare Faces Investigation Over Alleged Fraud

Rough Waters at Alignment Healthcare Not every day we hear about a company sinking its own ship over bookkeeping shenanigans, but here we are. Alignment Healthcare, sitting on Nasdaq under ticker ALHC, is facing the kind of scrutiny that sends shivers down a boardroom's spine. Yeah, Kahn Swick & Foti—those big hitters in securities litigation—have launched an...

Sabey Data Centers Tests HVO to Cut Emissions

Exploring New Horizons in Data Center Energy A curious tale is unfolding down in Austin, Texas, folks—one where data centers meet renewable energy in a bid to clean up their act. Sabey Data Centers is giving good old-fashioned diesel the boot in favor of hydrotreated vegetable oil (HVO) for backup power. We're not talking about minor tweaks here; this is about testing...

Enterprise AI: Bridging Trust Gaps and Unlocking Potential

Trusting AI to do the heavy lifting in business intelligence isn't as straightforward as flipping a switch. As organizations clamber onto the AI train, it’s clear they're leaving behind a treasure trove of institutional knowledge. We're talking decades of hard-earned data, research, and insights—just sitting there catching dust. So what's the kicker here? Cultivating...

California Housing Affordability Stagnant as Rates Rise

Numbers Tell the Story Get this: California's housing market's as sticky as day-old gum on a hot sidewalk. Despite a dip in home prices, affordability just won't budge. The California Association of REALTORS® (C.A.R.) says 19% of households could afford a median-priced home at $894,630, exactly like last quarter and even a year back. Not a flicker of change. Quirky it...

Lepage Millwork to Acquire Custom Window Maker Fenêtres MQ

Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...

Highway Motors Deal Reflects Shifts in Auto Trade

A Family Legacy Transitions in Virginia The trucking world doesn't stop spinning, and Highway Motors, an International dealer rooted deep in Virginia's soil since 1929, knows this intimately. This isn't just a back-of-the-napkin sale; it's a strategic move sweeping through the Interstate 81 corridor, touching Winchester, Harrisonburg, Roanoke, and Leesburg locales. What...

Reddit's Stock Plunge Sparks Legal Scrutiny

By Ryan Hughes Updated Oct 30, 2026 Category News Views 116

Reddit's Big Gamble: A Risky Shift Investors, grab your coffee, because Reddit (NYSE: RDDT) just gave us a real eyebrow-raiser, and no one's got a clue how deep this rabbit hole goes. They pulled the curtains back and went for a logged-in-only format, and the stock took a nosedive—a good 28% drop, just like that. If you've got a vested interest here, this is your cue to...

Emirates Wins 2026 Food Waste Award with Biodigester

Award Goes to Emirates for Sustainable Innovations Here's a twist in the waste management narrative: Emirates Flight Catering (EKFC) snagged the Best Food Waste Initiative of the Year 2026 at none other than the Middle East Waste & Recycling Awards. It's no small feat to stand out in an arena that's buzzing with initiatives left and right. So, what's their secret weapon?...